45 results about "Blood fluidity" patented technology

The invention discloses a functional nutritional agent for regulating the disharmony of intestinal florae and enhancing immunity and a preparation method thereof. The functional nutritional agent is prepared from four traditional Chinese medicines of Szechwan tangshen root, largehead atractylodes rhizome, Indian buead and honey-fried licorice in a weight ratio of 2:2:2:1 and spirulina, wherein a weight ratio of the four traditional Chinese medicines to the spirulina is 1-6:1-6. The preparation method comprises the following steps of: concentrating decoction of the four traditional Chinese medicines, inoculating lactobacillus to the concentrated decoction, and fermenting to obtain fermentation liquor of four gentlemen decoction; performing ultramicro crushing on the spirulina, inoculating bifidobacterium and fermenting to prepare fermentation liquor of the spirulina; and mixing the fermentation liquor of the four gentlemen decoction and the fermentation liquor of the spirulina, centrifuging to remove thalli, inactivating enzyme and drying to obtain the functional nutritional agent. The functional nutritional agent can prevent and correct the disharmony of the intestinal florae and enhance immunologic function, and also can protect hematopoietic function and blood liquidity, balance the metabolism of trace elements and improve endocrine function, so the functional nutritional agent is suitable for crew who perform long-distance navigation on naval vessels or submarines.

A blood rheology measurement device and a blood rheology measurement method which detect a fingerprint or a vein to thereby measure a positional relation between an artery in a living body and a sensor on the same conditions for each subject during non-invasive measurement and which correctly evaluate a change of blood rheology with elapse of time. A vein pattern or a fingerprint pattern peculiar to a subject is detected, recognized, and stored, a position of a sensor is adjusted so that the detected vein pattern or fingerprint pattern agrees with the stored vein pattern or fingerprint pattern every measurement, and a blood rheology index value indicating blood fluidity (fluidity / viscosity) is measured.

A blood fluidity-improving agent, a blood circulation promoter or a cerebrovascular disease-improving agent, containing as an active ingredient thereof one or more ingredients selected from the group consisting of chlorogenic acids, caffeic acids, ferulic acids and pharmaceutically acceptable salts of these acids. The present blood fluidity-improving agent, blood circulation promoter or cerebrovascular disease-improving agent is highly safe and can be orally taken over longer periods of time.

The composition of the present invention contains proanthocyanidins as active components. When the composition further comprises ascorbic acid or a derivative thereof, the fluidity of blood and effect of protecting blood vessels are further improved. This composition may be a food composition or pharmaceutical composition for improving the blood fluidity. Particularly, this composition is useful as a beverage.

To easily evaluate a fluidity of blood with high sensitivity. By winding a pressure bag body 10 around the surface of a skin of a finger tip 100 or the like of an examinee, and applying an oppression thereto, the blood in a capillary blood vessel under the skin is flown out to the surroundings, and by irradiating the skin where the oppression is applied with light from a light emitting element 21, and measuring a degree of the light absorption as a light reception quantity of a light receiving element 22, thereby optically measuring the change of a quantity of blood in the capillary blood vessel, and obtaining the quantity of blood in the capillary blood vessel with passage of time after applying the oppression, the fluidity of the blood (mainly viscosity μ) is evaluated.

Food compositions whereby natto kinase, which is a component of natto, can be easily taken; and food compositions comprising a combination of a Japanese food material natto with a western food material fermented milk product, for each of which some people have a dislike, so as to achieve the hygienic advantages of both of these materials and expect specific hygienic effects. Namely, food compositions comprising a freeze-dried fermented milk product, natto kinase and carriers usable in foods; and functional foods containing these components which have effects of preventing thrombosis, improving blood fluidity, preventing platelet aggregation and ameliorating lipid metabolism. These food compositions enable not only to easily take the components of the fermented milk product and natto without showing the characteristic smell of natto but also to achieve hygienic effects including amelioration in intestinal disorders, immnopotentiation and antitumor activity caused by the fermented milk product as well as the prevention and treatment of thrombosis owing to the synergistic effect thereof with natto kinase.

The present invention provides a composition for improving blood fluidity that comprises proanthocyanidins and an antioxidant (which is a substance other than proanthocyanidins, ascorbic acid and its derivatives) as active components. The composition for improving blood fluidity of the present invention improves blood flow in the body and further improves the fluidity of blood.

Blood fluidity is measured in a short time. A blood fluidity measurement system, which measures blood fluidity by flowing blood into a channel, is equipped with a TV camera which photographs the blood stream in the channel and an image processing part which detects the state of the blood stream in the channel as blood fluidity from the image taken by the TV camera.

The invention discloses a traditional Chinese medicine composition for effectively reducing blood viscosity. The traditional Chinese medicine composition is prepared from leeches, tortoise shells, sinopodophyllum hexandrum, lotus plumule, honeysuckle, stellaria uliginosa, caulis spatholobi, crinum asiaticum, semen cassiae, fructus gleditsiae and radix angelica sinensis. The invention further discloses a preparing method for the traditional Chinese medicine composition. The traditional Chinese medicine composition has the advantages of being good in curative effect, low in cost, high in cure rate and free of adverse reaction in the aspect of reducing blood viscosity. The traditional Chinese medicine composition can enhance the body physique of patients, improve blood mobility, reduce blood viscosity, and relieve various discomfort symptoms caused by blood viscosity; moreover, the preparing technology is simple, the toxic and side effect is small, the composition is easy to prepare, the raw materials are low in price, the preparing method is simple, and the traditional Chinese medicine composition has the good effects of reducing the blood viscosity and can be applied to clinical practice on a large scale.

The invention discloses a composite health care product which comprises the components by weight percent: 5-10 percent of propolis, 15-20 percent of royal jelly, 5-8 percent of dried rehmannia, 20-35 percent of ginkgo biloba leaf extract, 25-35 percent of wheat-germ oil and 25-30 percent of egg yolk lecithin. In this way, the composite health care product is capable of promoting blood circulation, improving the fluidity of blood, enhancing the human tolerance, energy and physical strength, and improving the memory and own resistance.

The composition of the present invention contains proanthocyanidins as active components. When the composition further comprises ascorbic acid or a derivative thereof, the fluidity of blood and effect of protecting blood vessels are further improved. This composition may be a food composition or pharmaceutical composition for improving the blood fluidity. Particularly, this composition is useful as a beverage.

The invention relates to the field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine formula for treating atherosclerosis. The traditional Chinese medicine formula for treating atherosclerosis is characterized by comprising the following components in parts by mass: 22-27 parts of hawthorns, 12-17 parts of polygonum multiflorum, 27-33 parts of polygonatum kingianum and 7-12 parts of honeysuckles. The powder of the components can be prepared into dosage forms such as decoction, paste, spray, concentrated tablets and pills. The formula belongs to the traditional Chinese medicine formula, and can be used for strengthening the body health of a patient, increasing blood liquidity and effectively relieving various unwell symptoms due to atherosclerosis. And moreover, the formula is simple in preparation process and low in price.

A blood fluidity improving agent, a blood flow promoting agent and a cerebrovascular disorder ameliorating agent containing, as the active ingredient, at least one member selected from among chlorogenic acids, caffeic acid, ferulaic acid and pharmaceutically acceptable salts thereof. The above-described blood fluidity improving agent, blood flow promoting agent and cerebrovascular disorder ameliorating agent are highly safe and can be taken over a long period of time.

The invention provides a melanin regeneration dropping pill, pertaining to the drugs used for curing Leucoderma, which is prepared from the raw materials of active ingredients of long pepper, fructus psoraleae, tribulus and angelica. The results of clinical use show that the invention has the following advantages of: 1) instant effect that the invention has quick results in 1-4 days; short course of treatment that the invention can cure the disease in 1-2 courses of treatment; high cure rate that the total cure rate is 84.2 percent; difficult recurrence; 2) the functions of reducing blood viscosity, promoting blood fluidity, improving microcirculation, increasing the content of copper-protein, lowering humoral immunity, enhancing cellular immunity and accelerating the melanin regeneration; 3) safe and effective clinical use and no obvious toxic side effect; 4) low treatment cost that the invention has the advantages of low cost and easy preparation, etc., compared with similar drugs used for curing Leucoderma, which can reduce the economic burden of a patient; 5) quick release and high bioavailability.

Black currant anthocyanin-containing compositions for foods comprising 1 to 25% by weight of black currant anthocyanin on the basis of solid matters; a process for producing a black currant anthocyanin-containing composition for foods characterized by purifying and concentrating black currant juice employed as a starting material by using a charged reverse osmosis membrane; functional foods and drinks characterized by containing the above compositions for foods; and the above-described compositions for foods and the above-described functional foods and drinks having an effect of improving visual function, a function of improving blood fluidity, and / or a function of lowering blood pressure. The conventional black currant anthocyanin compositions have a low black currant anthocyanin content, strong acidity and poor stability, which makes them unsuitable as additives for foods and drinks. However, the production process according to the present invention makes it possible to provide black currant anthocyanin-containing compositions for foods which have a high black currant anthocyanin content, an adequate acidity, and a high stability and can be added to foods and drinks. Moreover, functional foods and drinks containing these compositions, which have an effect of improving visual function, a function of improving blood fluidity, or a function of lowering blood pressure, can be provided.

Black currant anthocyanin-containing compositions for foods comprising 1 to 25% by weight of black currant anthocyanin on the basis of solid matters; a process for producing a black currant anthocyanin-containing composition for foods characterized by purifying and concentrating black currant juice employed as a starting material by using a charged reverse osmosis membrane; functional foods and drinks characterized by containing the above compositions for foods; and the above-described compositions for foods and the above-described functional foods and drinks having an effect of improving visual function, a function of improving blood fluidity, and / or a function of lowering blood pressure. The conventional black currant anthocyanin compositions have a low black currant anthocyanin content, strong acidity and poor stability, which makes them unsuitable as additives for foods and drinks. However, the production process according to the present invention makes it possible to provide black currant anthocyanin-containing compositions for foods which have a high black currant anthocyanin content, an adequate acidity, and a high stability and can be added to foods and drinks. Moreover, functional foods and drinks containing these compositions, which have an effect of improving visual function, a function of improving blood fluidity, or a function of lowering blood pressure, can be provided.

The invention discloses an anti-depression prescription for unobstructing Qi and blood. The anti-depression prescription is characterized by being prepared from the following components: 13 to 15 parts of rhizoma osmundae, 5 to 8 parts of fructus psoraleae, 0.2 to 0.37 part of fried euphorbia kansui, 9 to 10.8 parts of radix morindae officinalis, 2 to 6 parts of winged euonymus twig, 1.2 to 1.5 parts of Chinese pyrola herb, 3 to 4 parts of root of sunset abelmoschus, 2 to 2.6 parts of flos inulae, 0.38 to 0.4 part of humifuse euphorbia herb, 0.7 to 0.9 part of fructus toosendan and 3.6 to 5.9 parts of herba epimedii. The anti-depression prescription disclosed by the invention has the advantages that the rhizoma osmundae has the efficacy of clearing away heat and toxic materials, moistening lung and regulating Qi, tonifying deficiency and relaxing collateral channels and invigorating blood circulation and soothing stomach; the rhizoma osmundae is matched with the fructus toosendan and the fructus psoraleae, so that the effects of reducing blood viscosity and improving the blood fluidity can be realized, further the effects of soothing meridians and activating collaterals, and replenishing Qi and enriching the blood can be realized, and eventually, the depression, namely the melancholia can be treated from the source.

The invention provides a natural composition capable of improving blood micro-circulation disturbance and osteoporosis and a preparation method thereof. The natural composition is prepared from 10-20parts of a radix notoginseng extractive, 10-20 parts of a peach kernel extractive, 5-15 parts of a rhizoma drynariae extractive, 10-20 parts of a safflower extractive, 10-20 parts of an extractive from Angelica sinensis, 10-20 parts of a maca extractive and 5-15 parts of a licorice root extractive. The pharmaceutical composition contains various effective ingredients, for the synergic effect of different targets and information accesses, the effective ingredients are matched, blood vessels are expanded, blood viscosity is lowered, the blood flowability is improved, the blood microcirculation disturbance is improved, transportation and absorption of calcium, oxygen and other nutrients are promoted so as to improve the metabolic disorder states of osteoblasts and osteoclast, the bone mineraldensity, the bone calcium, the bone phosphate and the bone mineral content are increased, and the effect of treating osteoporosis is achieved. The composition adopts natural medicinal materials as raw materials, the multi-ingredient and multi-target synergic effect is achieved, both symptoms and root causes are addressed, and no toxic or side effect is caused.

The invention provides application of moroxydine in preparing a myocardial infarction therapeutic drug. According to the application of the moroxydine in preparing the myocardial infarction therapeutic drug, the regulating effect of the moroxydine on the cardiovascular system is examined through an experimental method, and the fact that the moroxydine can reduce blood viscosity, reduce serum creatine kinase activity and reduce thromboxane A2 (TXA2) level in plasma and also can up-regulate prostacyclin (PGI2) level in the plasma and improve serum superoxide dismutase (SOD) activity, so as to regulate angiotasis and promote blood fluidity is innovatively found. On the basis of the new properties of the moroxydine, by using the moroxydine as the myocardial infarction therapeutic drug, a protection effect on myocardial ischemic reperfusion damage can be realized, and cerebral infarction volume is reduced, so as to realize the treatment for myocardial infarction. The application provided by the invention is significant in drug therapeutic effect, rapid in effect and free of side effect, clinical experiments show that a higher cure rate is realized, and a huge popularization prospect is realized.

The invention relates to a hemoconcentrator shell, which comprises a cylinder body and end covers which are hermetically connected at both ends of the cylinder body, wherein Luer cone joints are arranged on the end covers; the cylinder body comprises a main cylinder body, a connecting cylinder body of which both ends are larger than the diameter of the main cylinder body, and a cone cylinder body which is connected between the main cylinder body and the connecting cylinder body, and the slenderness ratio of the cylinder body is between 6.5 and 8.5; two equidirectional and axially symmetrical tube holders are arranged on the cone cylinder body and extended to one side of the main cylinder body; liquid tube joints on the tube holders are communicated with an inner cavity of the main cylinder body; baffle plates on the inner wall of the main cylinder body are arranged at the bottom of the tube holders; internal threads on the end covers are connected with external threads of the connecting cylinder body in a mode of screwed joint; and seal rings which are arranged on the end face of the connecting cylinder body are arranged inside ring grooves of the end covers. The hemoconcentrator shell has the characteristics of convenient operation and good blood fluidity.

A blood rheology measurement device and a blood rheology measurement method which detect a fingerprint or a vein to thereby measure a positional relation between an artery in a living body and a sensor on the same conditions for each subject during non-invasive measurement and which correctly evaluate a change of blood rheology with elapse of time. A vein pattern or a fingerprint pattern peculiar to a subject is detected, recognized, and stored, a position of a sensor is adjusted so that the detected vein pattern or fingerprint pattern agrees with the stored vein pattern or fingerprint pattern every measurement, and a blood rheology index value indicating blood fluidity (fluidity / viscosity) is measured.

The invention provides a blood small-molecular grouping processor for a hemodialysis machine and relates to an instrument which is specially used together with a hemodialysis machine to play a health-care role on the health of patients with hemodialysis. The blood small-molecular grouping processor can perform magnetization treatment on human blood to realize small-molecular grouping of blood and has the health-care functions of strengthening blood fluidity, improving blood circulation, enhancing microcirculation, improving immunity and the like. The blood small-molecular grouping processor comprises a blood conveying pipeline, a processor body, a plurality of magnetic element components, a left-side end plate, a right-side end plate, a lower positioning part and an upper positioning part, wherein the magnetic element components are positioned in the processor body; the blood conveying pipeline is positioned by the upper positioning part and the lower positioning part and axially mounted among the magnetic element components; side plates are mounted on two sides of the processor body, and a blood conveying pipeline clamping groove is formed in each side plate. The blood small-molecular grouping processor is compact, simple and quick in use, easy to operate, convenient for sterilization treatment and convenient to maintain.

A blood fluidity-improving agent, a blood circulation promoter or a cerebrovascular disease-improving agent, containing as an active ingredient thereof one or more ingredients selected from the group consisting of chlorogenic acids, caffeic acids, ferulic acids and pharmaceutically acceptable salts of these acids. The present blood fluidity-improving agent, blood circulation promoter or cerebrovascular disease-improving agent is highly safe and can be orally taken over longer periods of time.

A blood fluidity improving agent, a blood flow promoting agent and a cerebrovascular disorder ameliorating agent containing, as the active ingredient, at least one member selected from among chlorogenic acids, caffeic acid, ferulaic acid and pharmaceutically acceptable salts thereof. The above-described blood fluidity improving agent, blood flow promoting agent and cerebrovascular disorder ameliorating agent are highly safe and can be taken over a long period of time.

The invention provides a melanin regeneration dropping pill, pertaining to the drugs used for curing Leucoderma, which is prepared from the raw materials of active ingredients of long pepper, fructus psoraleae, tribulus and angelica. The results of clinical use show that the invention has the following advantages of: 1) instant effect that the invention has quick results in 1-4 days; short courseof treatment that the invention can cure the disease in 1-2 courses of treatment; high cure rate that the total cure rate is 84.2 percent; difficult recurrence; 2) the functions of reducing blood viscosity, promoting blood fluidity, improving microcirculation, increasing the content of copper-protein, lowering humoral immunity, enhancing cellular immunity and accelerating the melanin regeneration; 3) safe and effective clinical use and no obvious toxic side effect; 4) low treatment cost that the invention has the advantages of low cost and easy preparation, etc., compared with similar drugs used for curing Leucoderma, which can reduce the economic burden of a patient; 5) quick release and high bioavailability.

The invention provides a traditional Chinese medicine composition for treating the coronary heart disease. The traditional Chinese medicine composition is characterized by comprising the following traditional Chinese medicine components in parts by weight of 20 grams of radix codonopsis, 30 grams of spina date seeds, 25 grams of radix astragali, 12 grams of radix ophiopogonis, 15 grams of Chinesetaxillus herbs, 6 grams of Chinese magnoliavine fruits and 30 grams of motherwort. The traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition belongs to a traditional Chinese medicine formula, body constitutions of a patient can be strengthened, blood flow can be increased, various discomfort symptoms caused by the coronary heart disease can be obviously improved, and the traditional Chinese medicine composition is low in price.

The invention discloses a rhinitis inhibiting and repairing therapeutic apparatus which comprises a body and a physical therapy device electrically connected with the body, the physical therapy device comprises two physical therapy heads matched with nostrils of a human body, the physical therapy device comprises a light source assembly, and the light source assembly comprises a first light-emitting part and a second light-emitting part which output light sources with different wavelengths and light colors. The light source assembly and the physiotherapy head are arranged in a matched mode, the first light-emitting part outputs red light, the second light-emitting part outputs blue light, the red light can play a role in accelerating blood circulation, promoting wound healing and eliminating inflammation, and the blue light can play a role in changing blood fluidity and viscosity and further rapidly inhibiting inflammation. And a user can flexibly select, the function is powerful, and the use is convenient.

The present invention relates to an apparatus and a method for measuring a hemostatic function using blood mobility. The present invention can comprise a measurement kit; and one or more capillaries provided at the measurement kit in which a blood inlet is formed at one end and an opening communicating with the outside is formed at the other end. In addition, recesses inwardly recessed can be formed longitudinally on at least one lateral side of the capillaries. According to the present invention, it is possible to rapidly measure the hemostatic function of blood and to examine multiple samples at one time by measuring the mobility of a very small amount of blood moving the capillaries.

The invention relates to a hemoconcentrator shell, which comprises a cylinder body and end covers which are hermetically connected at both ends of the cylinder body, wherein Luer cone joints are arranged on the end covers; the cylinder body comprises a main cylinder body, a connecting cylinder body of which both ends are larger than the diameter of the main cylinder body, and a cone cylinder bodywhich is connected between the main cylinder body and the connecting cylinder body, and the slenderness ratio of the cylinder body is between 6.5 and 8.5; two equidirectional and axially symmetrical tube holders are arranged on the cone cylinder body and extended to one side of the main cylinder body; liquid tube joints on the tube holders are communicated with an inner cavity of the main cylinder body; baffle plates on the inner wall of the main cylinder body are arranged at the bottom of the tube holders; internal threads on the end covers are connected with external threads of the connecting cylinder body in a mode of screwed joint; and seal rings which are arranged on the end face of the connecting cylinder body are arranged inside ring grooves of the end covers. The hemoconcentrator shell has the characteristics of convenient operation and good blood fluidity.

The invention relates to the field of traditional Chinese medicines, and particularly relates to a formula of traditional Chinese medicine for treating hyperlipemia. According to the formula, the traditional Chinese medicine for treating hyperlipemia is characterized by being prepared from the following components in parts by weight: 12-17 parts of haw flakes, 12-17 parts of rhizoma alismatis, 27-33 parts of fructus lycii and 6-10 parts of codonopsis pilosula. The powdered material prepared from the components can be made into decoction, ointment, spray, concentrated tablets, pills and other dosage forms. The formula belongs to a traditional Chinese medicine formula and is capable of enhancing the constitutions of patient bodies, improving blood fluidity, reducing blood viscosity and relieving various discomfort symptoms caused by hyperlipemia; and the traditional Chinese medicine based on the formula is simple in manufacture process and low in price.